Compared with DPP-4i use, GLP-1 RA use also associated with lower risk for composite of cirrhosis complications, mortality

No associations seen for preeclampsia or eclampsia or gestational diabetes

Lower odds of eye-care visits seen for Black and White patients with diabetes living in rural communities with preexisting DR

Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage

Once-weekly efsitora noninferior to once-daily degludec for decrease in mean glycated hemoglobin level

Findings independent of energy intake and based on eight-hour eating window, regardless of time of day

Liraglutide results in greater reduction in BMI than placebo plus lifestyle intervention for children with obesity

CDC data show that in 23 states, 35 percent or more of the population is now obese

Twenty-six positive, five negative correlations seen, as well as link between insulin resistance and all-cause mortality in women

Those with late versus intermediate chronotype also have higher BMI, larger waist circumference, more visceral fat and liver fat